Information for Providers
Community providers are especially encouraged to refer patients with bipolar disorders for possible study inclusion. Eligible patients receive the extra support and benefits of study participation and referring providers receive the extra assistance of the Bipolar Disorders Clinic in evaluating and managing their bipolar patients.
Patients partipating in pharmaceutical company sponsored clinical trials are eligible for free medication, hospitalization (for inpatient studies), and medication monitoring for the duration of the study, which varies from a few weeks to 18 months. These patients may continue to see their current provider for supportive therapy and return to their regular psychiatrist at the end of the study.
Consultations include review of medical records, extended interview with the patient, a comprehensive written report and treatment recommendations. The report and treatment recommendations are typically faxed to the referring provider within 48 hours.
Medical records may be faxed directly to the Clinic at (650) 723-2507.